MicroStrategy (MSTR) 10-Q 28 Apr 20 2020 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2020	Apr. 20, 2020
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Trading Symbol	MSTR
Entity Registrant Name	MICROSTRATEGY INCORPORATED
Entity Central Index Key	0001050446
Entity Interactive Data Current	Yes
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Title of 12(b) Security	Class A common stock, par value $0.001 per share
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity File Number	000-24435
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	51-0323571
Entity Address, Address Line One	1850 Towers Crescent Plaza
Entity Address, City or Town	Tysons Corner
Entity Address, State or Province	VA
Entity Address, Postal Zip Code	22182
City Area Code	703
Local Phone Number	848-8600
Document Quarterly Report	true
Document Transition Report	false
Class A
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		7,728,917
Class B Convertible
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		2,035,184

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 429,276	$ 456,727
Restricted cash	2,742	1,089
Short-term investments	109,946	108,919
Accounts receivable, net	124,935	163,516
Prepaid expenses and other current assets	26,163	23,195
Total current assets	693,062	753,446
Property and equipment, net	47,623	50,154
Right-of-use assets	82,690	85,538
Deposits and other assets	7,757	8,024
Deferred tax assets, net	18,139	19,409
Total assets	849,271	916,571
Current liabilities:
Accounts payable, accrued expenses, and operating lease liabilities	32,539	33,919
Accrued compensation and employee benefits	35,207	48,792
Deferred revenue and advance payments	184,891	187,107
Total current liabilities	252,637	269,818
Deferred revenue and advance payments	3,660	4,344
Operating lease liabilities	100,251	103,424
Other long-term liabilities	31,273	30,400
Deferred tax liabilities	24	26
Total liabilities	387,845	408,012
Commitments and Contingencies
Stockholders’ Equity
Preferred stock undesignated, $0.001 par value; 5,000 shares authorized; no shares issued or outstanding	0	0
Additional paid-in capital	597,087	593,583
Treasury stock, at cost; 8,162 shares and 7,807 shares, respectively	(709,627)	(658,880)
Accumulated other comprehensive loss	(10,198)	(9,651)
Retained earnings	584,146	583,489
Total stockholders’ equity	461,426	508,559
Total liabilities and stockholders’ equity	849,271	916,571
Class A
Stockholders’ Equity
Common stock	16	16
Total stockholders’ equity	16	16
Class B Convertible
Stockholders’ Equity
Common stock	2	2
Total stockholders’ equity	$ 2	$ 2

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Mar. 31, 2020	Dec. 31, 2019
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Treasury stock, shares	8,162,000	7,807,000
Class A
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	330,000,000	330,000,000
Common stock, shares issued	15,891,000	15,888,000
Common stock, shares outstanding	7,729,000	8,081,000
Class B Convertible
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	165,000,000	165,000,000
Common stock, shares issued	2,035,000	2,035,000
Common stock, shares outstanding	2,035,000	2,035,000

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands		3 Months Ended
		Mar. 31, 2020	Mar. 31, 2019
Revenues:
Total revenues		$ 111,424	$ 115,366
Cost of revenues:
Total cost of revenues		24,545	26,173
Gross profit		86,879	89,193
Operating expenses:
Sales and marketing		39,518	48,760
Research and development		26,101	28,215
General and administrative		21,332	22,604
Total operating expenses		86,951	99,579
Loss from operations		(72)	(10,386)
Interest income, net		1,855	2,566
Other income (expense), net		434	(596)
Income (loss) before income taxes		2,217	(8,416)
Provision for (benefit from) income taxes		1,560	(510)
Net income (loss)		$ 657	$ (7,906)
Basic earnings (loss) per share	[1]	$ 0.07	$ (0.77)
Weighted average shares outstanding used in computing basic earnings (loss) per share		9,976	10,328
Diluted earnings (loss) per share	[1]	$ 0.07	$ (0.77)
Weighted average shares outstanding used in computing diluted earnings (loss) per share		10,031	10,328
Product licenses
Revenues:
Total revenues		$ 12,584	$ 18,291
Cost of revenues:
Total cost of revenues		670	519
Subscription services
Revenues:
Total revenues		7,968	7,144
Cost of revenues:
Total cost of revenues		4,064	3,598
Total product licenses and subscription services
Revenues:
Total revenues		20,552	25,435
Cost of revenues:
Total cost of revenues		4,734	4,117
Product support
Revenues:
Total revenues		71,158	71,450
Cost of revenues:
Total cost of revenues		6,718	7,067
Other services
Revenues:
Total revenues		19,714	18,481
Cost of revenues:
Total cost of revenues		$ 13,093	$ 14,989
[1]	Basic and fully diluted earnings (loss) per share for class A and class B common stock are the same.

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Statement Of Income And Comprehensive Income [Abstract]
Net income (loss)	$ 657	$ (7,906)
Other comprehensive income (loss), net of applicable taxes:
Foreign currency translation adjustment	(1,171)	(162)
Unrealized gain on short-term investments	624	415
Total other comprehensive (loss) income	(547)	253
Comprehensive income (loss)	$ 110	$ (7,653)

CONSOLIDATED STATEMENTS OF STOC

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Class A	Class B Convertible	Additional Paid-in Capital	Treasury Stock	Accumulated Other Comprehensive Income (Loss)	Retained Earnings
Beginning Balance at Dec. 31, 2018	$ 529,731	$ 16	$ 2	$ 576,957	$ (586,161)	$ (10,217)	$ 549,134
Beginning Balance (in shares) at Dec. 31, 2018		15,837	2,035		(7,285)
Net income (loss)	(7,906)	$ 0	$ 0	0	$ 0	0	(7,906)
Other comprehensive income (loss)	253	0	0	0	0	253	0
Issuance of class A common stock under stock option plans	1,507	$ 0	$ 0	1,507	$ 0	0	0
Issuance of class A common stock under stock option plans (in shares)		13	0		0
Purchases of treasury stock	(48,244)	$ 0	$ 0	0	$ (48,244)	0	0
Purchases of treasury stock (in shares)		0	0		(363)
Share-based compensation expense	2,965	$ 0	$ 0	2,965	$ 0	0	0
Ending Balance at Mar. 31, 2019	478,306	$ 16	$ 2	581,429	$ (634,405)	(9,964)	541,228
Ending Balance (in shares) at Mar. 31, 2019		15,850	2,035		(7,648)
Net income (loss)	20,394	$ 0	$ 0	0	$ 0	0	20,394
Other comprehensive income (loss)	654	0	0	0	0	654	0
Issuance of class A common stock under stock option plans	329	$ 0	$ 0	329	$ 0	0	0
Issuance of class A common stock under stock option plans (in shares)		3	0		0
Share-based compensation expense	3,006	$ 0	$ 0	3,006	$ 0	0	0
Ending Balance at Jun. 30, 2019	502,689	$ 16	$ 2	584,764	$ (634,405)	(9,310)	561,622
Ending Balance (in shares) at Jun. 30, 2019		15,853	2,035		(7,648)
Net income (loss)	9,700	$ 0	$ 0	0	$ 0	0	9,700
Other comprehensive income (loss)	(2,364)	0	0	0	0	(2,364)	0
Issuance of class A common stock under stock option plans	3,606	$ 0	$ 0	3,606	$ 0	0	0
Issuance of class A common stock under stock option plans (in shares)		27	0		0
Share-based compensation expense	1,788	$ 0	$ 0	1,788	$ 0	0	0
Ending Balance at Sep. 30, 2019	515,419	$ 16	$ 2	590,158	$ (634,405)	(11,674)	571,322
Ending Balance (in shares) at Sep. 30, 2019		15,880	2,035		(7,648)
Net income (loss)	12,167	$ 0	$ 0	0	$ 0	0	12,167
Other comprehensive income (loss)	2,023	0	0	0	0	2,023	0
Issuance of class A common stock under stock option plans	1,127	$ 0	$ 0	1,127	$ 0	0	0
Issuance of class A common stock under stock option plans (in shares)		8	0		0
Purchases of treasury stock	(24,475)	$ 0	$ 0	0	$ (24,475)	0	0
Purchases of treasury stock (in shares)		0	0		(159)
Share-based compensation expense	2,298	$ 0	$ 0	2,298	$ 0	0	0
Ending Balance at Dec. 31, 2019	508,559	$ 16	$ 2	593,583	$ (658,880)	(9,651)	583,489
Ending Balance (in shares) at Dec. 31, 2019		15,888	2,035		(7,807)
Net income (loss)	657	$ 0	$ 0	0	$ 0	0	657
Other comprehensive income (loss)	(547)	0	0	0	0	(547)	0
Issuance of class A common stock under stock option plans	340	$ 0	$ 0	340	$ 0	0	0
Issuance of class A common stock under stock option plans (in shares)		3	0		0
Purchases of treasury stock	(50,747)	$ 0	$ 0	0	$ (50,747)	0	0
Purchases of treasury stock (in shares)		0	0		(355)
Share-based compensation expense	3,164	$ 0	$ 0	3,164	$ 0	0	0
Ending Balance at Mar. 31, 2020	$ 461,426	$ 16	$ 2	$ 597,087	$ (709,627)	$ (10,198)	$ 584,146
Ending Balance (in shares) at Mar. 31, 2020		15,891	2,035		(8,162)

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Operating activities:
Net income (loss)	$ 657	$ (7,906)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	2,756	1,657
Reduction in carrying amount of right-of-use assets	2,053	2,007
Credit losses and sales allowances	828	827
Net realized loss on short-term investments	0	41
Deferred taxes	957	(1,694)
Share-based compensation expense	3,111	3,017
Changes in operating assets and liabilities:
Accounts receivable	14,406	10,266
Prepaid expenses and other current assets	(3,295)	(3,070)
Deposits and other assets	84	(134)
Accounts payable and accrued expenses	(154)	(3,108)
Accrued compensation and employee benefits	(13,031)	(12,195)
Deferred revenue and advance payments	22,001	38,502
Operating lease liabilities	(2,238)	(2,074)
Other long-term liabilities	934	320
Net cash provided by operating activities	29,069	26,456
Investing activities:
Proceeds from redemption of short-term investments	10,000	314,403
Purchases of property and equipment	(661)	(6,011)
Purchases of short-term investments	(9,928)	(138,099)
Net cash (used in) provided by investing activities	(589)	170,293
Financing activities:
Proceeds from sale of class A common stock under exercise of employee stock options	340	1,507
Purchases of treasury stock	(50,747)	(48,244)
Net cash used in financing activities	(50,407)	(46,737)
Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash	(3,871)	(1,133)
Net (decrease) increase in cash, cash equivalents, and restricted cash	(25,798)	148,879
Cash, cash equivalents, and restricted cash, beginning of period	457,816	110,786
Cash, cash equivalents, and restricted cash, end of period	$ 432,018	$ 259,665

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	(1) Summary of Significant Accounting Policies (a) Basis of Presentation The accompanying Consolidated Financial Statements of MicroStrategy Incorporated (“MicroStrategy” or the “Company”) are unaudited. In the opinion of management, all adjustments necessary for a fair statement of financial position and results of operations have been included. All such adjustments are of a normal recurring nature, unless otherwise disclosed. Interim results are not necessarily indicative of results for a full year. Certain amounts in the prior year’s Consolidated Statements of Cash Flows have been reclassified to conform to current year presentation. In particular, reductions in the carrying amount of right-of-use (“ROU”) assets have been reclassified from “Depreciation and amortization” to “Reduction in carrying amount of right-of-use assets” in operating activities. As discussed in Note 2, Recent Accounting Standards, to the Consolidated Financial Statements, the Company adopted Accounting Standards Update No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, The Consolidated Financial Statements and Notes to Consolidated Financial Statements are presented as required by the United States Securities and Exchange Commission (“SEC”) and do not contain certain information included in the Company’s annual financial statements and notes. These financial statements should be read in conjunction with the Company’s audited financial statements and the notes thereto filed with the SEC in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019. There have been no significant changes in the Company’s accounting policies since December 31, 2019, except as discussed below with respect to the Company’s adoption of ASU 2016-13. The accompanying Consolidated Financial Statements include the accounts of the Company and its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. The Company is not aware of any material subsequent event that would require recognition or disclosure. (b) Short-term Investments The Company periodically invests a portion of its excess cash in short-term investment instruments. All highly liquid investments with stated maturity dates between three months and one year from the purchase date are classified as short-term investments. The Company determines the appropriate classification of its short-term investments at the time of purchase and reassesses the appropriateness of the classification at each reporting date. All of the Company’s short-term investments are in U.S. Treasury securities. All short-term investments have been classified as available-for-sale and are reported at fair value within “Short-term investments” on the accompanying Consolidated Balance Sheets. The fair value of the Company’s short-term investments is determined based on quoted market prices in active markets for identical securities (Level 1 inputs). Premiums and discounts related to the Company’s short-term investments are amortized over the life of the investment and recorded in earnings. Each reporting period, the Company determines the amount of unrealized holding gains and losses on each individual security by comparing the fair value to the amortized cost. Unrealized holding gains and unrealized holding losses that are not a result of a credit loss are reported in other comprehensive income (loss) until realized. Beginning January 1, 2020, unrealized holding losses that are a result of a credit loss are recorded in earnings, with the establishment of an allowance for credit losses. (c) Credit Losses on Accounts Receivable The Company maintains an allowance for credit losses on its accounts receivable balances, which represents its best estimate of current expected credit losses over the contractual life of the accounts receivable. Beginning January 1, 2020, when evaluating the adequacy of its allowance for credit losses each reporting period, the Company analyzes accounts receivable balances with similar risk characteristics on a collective basis, considering factors such as the aging of receivable balances, payment terms, geographic location, historical loss experience, current information, and future expectations. Each reporting period, the Company reassesses whether any accounts receivable no longer share similar risk characteristics and should instead be evaluated as part of another pool or on an individual basis. Changes to the allowance for credit losses are adjusted through credit loss expense, which is presented within “General and administrative” operating expenses in the Consolidated Statements of Operations.

Recent Accounting Standards

Recent Accounting Standards	3 Months Ended
	Mar. 31, 2020
Accounting Changes And Error Corrections [Abstract]
Recent Accounting Standards	(2) Recent Accounting Standards Credit losses The Company adopted ASU 2016-13 effective as of January 1, 2020. Under ASU 2016-13, the Company applies a current expected credit loss (“CECL”) impairment model to its trade accounts receivable, in which lifetime expected credit losses on such financial assets are measured and recognized at each reporting date based on historical, current, and forecasted information. Under the CECL model, trade accounts receivable with similar risk characteristics are analyzed on a collective (pooled) basis. ASU 2016-13 also changed the impairment accounting for available-for-sale debt securities, requiring credit losses to be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. Impairment due to factors other than credit loss will continue to be recorded through other comprehensive income (loss). All of the Company’s available-for-sale debt securities are in U.S. Treasury securities with stated maturity dates between three months and one year from the purchase date and any impairments are not expected to result from credit losses. Although classified as available-for-sale, the Company does not generally intend to sell these investments prior to their maturity dates, nor is it likely the Company would be required to sell these investments prior to recovery of any impairment. The adoption of this guidance did not have a material impact on the Company’s consolidated financial position, results of operations, or cash flows. No cumulative-effect adjustment to retained earnings was made. Cloud computing arrangements The Company adopted Accounting Standards Update No. 2018-15, Intangibles – Goodwill and Other – Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract Accounting for income taxes In December 2019, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes

Short-term Investments

Short-term Investments	3 Months Ended
	Mar. 31, 2020
Short Term Investments [Abstract]
Short-term Investments	(3) Short-term Investments The amortized cost and fair value of available-for-sale investments at March 31, 2020 were $109.2 million and $109.9 million, respectively. The amortized cost and fair value of available-for-sale investments at December 31, 2019 were $108.8 million and $108.9 million, respectively. The gross unrecognized holding gains accumulated in other comprehensive loss were not material as of March 31, 2020 and December 31, 2019. As of March 31, 2020 and December 31, 2019, none of the Company’s available-for-sale investments were in unrealized loss positions.

Contract Balances

Contract Balances	3 Months Ended
	Mar. 31, 2020
Contract With Customer Asset And Liability [Abstract]
Contract Balances	(4) Contract Balances The Company invoices its customers in accordance with billing schedules established in each contract. The Company’s rights to consideration from customers are presented separately in the Company’s Consolidated Balance Sheets depending on whether those rights are conditional or unconditional. The Company presents unconditional rights to consideration from customers within “Accounts receivable, net” in its Consolidated Balance Sheets. All of the Company’s contracts are generally non-cancellable and/or non-refundable, and therefore an unconditional right generally exists when the customer is billed or amounts are billable per the contract. Accounts receivable (in thousands) consisted of the following, as of: March 31, December 31, 2020 2019 Billed and billable $ 126,971 $ 165,153 Less: allowance for credit losses (2,036 ) (1,637 ) Accounts receivable, net $ 124,935 $ 163,516 Changes in the allowance for credit losses were not material for the three months ended March 31, 2020. In estimating its allowance for credit losses as of March 31, 2020, the Company considered the impact from the pandemic caused by a novel strain of coronavirus (“COVID-19”) and considered additional risk pools and reserves relating to customers in certain geographic areas and industries. Rights to consideration that are subject to a condition other than the passage of time are considered contract assets and presented within “Prepaid expenses and other current assets” in the Consolidated Balance Sheets since the rights to consideration are expected to become unconditional and transfer to accounts receivable within one year. Contract assets generally consist of accrued sales and usage-based royalty revenue. In these arrangements, consideration is not billed or billable until the royalty reporting is received, generally in the subsequent quarter, at which time the contract asset transfers to accounts receivable and a true-up adjustment is recorded to revenue. These true-up adjustments are generally not material. During the three months ended March 31, 2020 and 2019, there were no significant impairments to the Company’s contract assets, nor were there any significant changes in the timing of the Company’s contract assets being reclassified to accounts receivable. Contract assets included in “Prepaid expenses and other current assets” in the Consolidated Balance Sheets consisted of $1.1 million and $1.2 million in accrued sales and usage-based royalty revenue as of March 31, 2020 and December 31, 2019, respectively. Contract liabilities are amounts received or due from customers in advance of the Company transferring the software or services to the customer. Revenue is subsequently recognized in the period(s) in which control of the software or services is transferred to the customer. The Company’s contract liabilities are presented as either current or non-current “Deferred revenue and advance payments” in the Consolidated Balance Sheets, depending on whether the software or services are expected to be transferred to the customer within the next year. The Company’s “Accounts receivable, net” and “Deferred revenue and advance payments” balances in the Consolidated Balance Sheets include unpaid amounts related to contracts under which the Company has an enforceable right to invoice the customer for non-cancellable and/or non-refundable software and services. Changes in accounts receivable and changes in deferred revenue and advance payments are presented net of these unpaid amounts in “Operating activities” in the Consolidated Statements of Cash Flows. Deferred revenue and advance payments (in thousands) from customers consisted of the following, as of: March 31, December 31, 2020 2019 Current: Deferred product licenses revenue $ 131 $ 481 Deferred subscription services revenue 16,567 16,561 Deferred product support revenue 161,135 161,670 Deferred other services revenue 7,058 8,395 Total current deferred revenue and advance payments $ 184,891 $ 187,107 Non-current: Deferred product licenses revenue $ 262 $ 293 Deferred subscription services revenue 84 97 Deferred product support revenue 2,789 3,417 Deferred other services revenue 525 537 Total non-current deferred revenue and advance payments $ 3,660 $ 4,344 During the three months ended March 31, 2020, the Company recognized revenues of $69.2 million from amounts included in the total deferred revenue and advance payments balances at the beginning of 2020. During the three months ended March 31, 2019, the Company recognized revenues of $67.0 million from amounts included in the total deferred revenue and advance payments balances at the beginning of 2019. For the three months ended March 31, 2020 and 2019, there were no significant changes in the timing of revenue recognition on the Company’s deferred balances. As of March 31, 2020, the Company had an aggregate transaction price of $188.6 million allocated to remaining performance obligations related to product support, subscription services, other services, and, in limited cases, product licenses contracts. The Company expects to recognize $184.9 million within the next 12 months and $3.7 million thereafter

Leases

Leases	3 Months Ended
	Mar. 31, 2020
Leases [Abstract]
Leases	(5) Leases The Company leases office space in the United States and foreign locations under operating lease agreements. Office space is the Company’s only material underlying asset class under operating lease agreements. The Company has no material finance leases. Under the Company’s office space lease agreements, fixed payments and variable payments that depend on an index or rate are typically comprised of base rent and parking fees. Additionally, under these agreements the Company is generally responsible for certain variable payments that typically include certain taxes, utilities and maintenance costs, and other fees. These variable lease payments are generally based on the Company’s occupation or usage percentages and are subject to adjustments by the lessor. As of March 31, 2020, the Company’s ROU assets and total lease liabilities were $69.9 million and $96.1 million, respectively, for leases in the United States and $12.8 million and $13.7 million, respectively, for foreign leases. As of December 31, 2019, the Company’s ROU assets and total lease liabilities were $71.0 million and $97.5 million, respectively, for leases in the United States and $14.5 million and $15.5 million, respectively, for foreign leases. The Company’s most significant lease is for its corporate headquarters in Northern Virginia. The ROU asset and total lease liability related to the Company’s corporate headquarters lease were $66.0 million and $92.1 million, respectively, as of March 31, 2020, and $66.9 million and $93.3 million, respectively, as of December 31, 2019. During the three months ended March 31, 2020, there were no ROU assets obtained in exchange for new operating lease liabilities. During the three months ended March 31, 2019, $1.0 million of ROU assets were obtained in exchange for new operating lease liabilities.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2020
Commitments And Contingencies Disclosure [Abstract]
Commitments and Contingencies	(6) Commitments and Contingencies (a) Commitments From time to time, the Company enters into certain types of contracts that require it to indemnify parties against third-party claims. These contracts primarily relate to agreements under which the Company assumes indemnity obligations for intellectual property infringement, as well as other obligations from time to time depending on arrangements negotiated with customers and other third parties. The conditions of these obligations vary. Thus, the overall maximum amount of the Company’s indemnification obligations cannot be reasonably estimated. Historically, the Company has not been obligated to make significant payments for these obligations and does not currently expect to incur any material obligations in the future. Accordingly, the Company has not recorded an indemnification liability on its Balance Sheets as of March 31, 2020 or December 31, 2019. See Note 5, Leases, to the Consolidated Financial Statements for information regarding the Company’s commitments that are related to lease agreements. See Note 8, Income Taxes, to the Consolidated Financial Statements for information regarding the Company’s commitments that are related to a mandatory deemed repatriation transition tax (“Transition Tax”) imposed under the U.S. Tax Cuts and Jobs Act (the “Tax Act”). (b) Contingencies Following an internal review initiated in 2018, the Company believes that its Brazilian subsidiary failed or likely failed to comply with local procurement regulations in conducting business with certain Brazilian government entities. On February 6, 2020, the Company learned that a Brazilian court has authorized the Brazilian Federal Police to use certain investigative measures in its investigation into alleged corruption and procurement fraud involving certain government officials, pertaining to a particular transaction. Pursuant to this court authorization, numerous entities and individuals across Brazil, which are unaffiliated with the Company, have been subject to the freezing of assets and other measures, including a reseller and a former employee of the Company’s Brazilian subsidiary. On February 6, 2020, the bank accounts of the Company’s Brazilian subsidiary were also frozen up to an amount of BRL 10.0 million, or approximately $2.3 million. As of March 31, 2020, the balance of these frozen bank accounts has been classified as “Restricted cash” in the Consolidated Balance Sheets. The transaction at issue is part of the basis of the previously reported failure or likely failure of the Brazilian subsidiary to comply with local procurement regulations. The Company is not a subject of the investigation, and the Company is not aware of any allegations that the former employee or the Company made any payments to Brazilian government officials. While the Company believes that it is probable that the resolution of these Brazilian matters will result in a loss, the amount or range of loss is not reasonably estimable at this time. Given the stage of these matters, the outcome may result in a material impact on the Company’s earnings and financial results for the period in which any such liability is accrued. However, the Company believes that the outcome of these matters will not have a material effect on the Company’s financial position. The Company is also involved in various legal proceedings arising in the normal course of business. Although the outcomes of these legal proceedings are inherently difficult to predict, management does not expect the resolution of these legal proceedings to have a material adverse effect on the Company’s financial position, results of operations, or cash flows. The Company has contingent liabilities that, in management’s judgment, are not probable of assertion. If such unasserted contingent liabilities were to be asserted, or become probable of assertion, the Company may be required to record significant expenses and liabilities in the period in which these liabilities are asserted or become probable of assertion.

Treasury Stock

Treasury Stock	3 Months Ended
	Mar. 31, 2020
Equity [Abstract]
Treasury Stock	(7) Treasury Stock The Board of Directors has authorized the Company’s repurchase of up to an aggregate of $800.0 million of its class A common stock from time to time on the open market through April 29, 2023 (the “Share Repurchase Program”), although the program may be suspended or discontinued by the Company at any time. The timing and amount of any shares repurchased will be determined by the Company’s management based on its evaluation of market conditions and other factors. The Share Repurchase Program may be funded using the Company’s working capital, as well as proceeds from any other funding arrangements that the Company may enter into in the future. During the three months ended March 31, 2020, the Company repurchased an aggregate of 354,633 shares of its class A common stock at an average price per share of $143.10 and an aggregate cost of $50.7 million pursuant to the Share Repurchase Program. During the three months ended March 31, 2019, the Company repurchased an aggregate of 362,148 shares of its class A common stock at an average price per share of $133.21 and an aggregate cost of $48.2 million pursuant to the Share Repurchase Program. As of March 31, 2020, the Company had repurchased an aggregate of 5,584,090 shares of its class A common stock at an average price per share of $103.82 and an aggregate cost of $579.7 million pursuant to the Share Repurchase Program. As of March 31, 2020, $220.3 million of the Company’s class A common stock remained available for repurchase pursuant to the Share Repurchase Program. The average price per share and aggregate cost amounts disclosed above include broker commissions.

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2020
Income Tax Disclosure [Abstract]
Income Taxes	(8) Income Taxes The Company and its subsidiaries conduct business in the United States and various foreign countries and are subject to taxation in numerous domestic and foreign jurisdictions. As a result of its business activities, the Company files tax returns that are subject to examination by various U.S. federal, state, and local, and foreign tax authorities. With few exceptions, the Company is no longer subject to U.S. federal, state and local, or foreign income tax examination by tax authorities for years before 2016. However, due to the Company’s use of state net operating loss (“NOL”) carryovers in the United States, state tax authorities may attempt to reduce or fully offset the amount of state NOL carryovers from tax years ended 2011 and forward that the Company used in later tax years. The Company’s major foreign tax jurisdictions and tax years that remain subject to potential examination are Poland for tax years 2015 and forward, Spain, Germany, and Italy for tax years 2016 and forward, and the United Kingdom for tax years 2018 and forward. To date there have been no material audit assessments related to audits in any of the applicable foreign jurisdictions. As of March 31, 2020, the Company had unrecognized tax benefits of $2.6 million, which are recorded in “Other long-term liabilities” in the Company’s Consolidated Balance Sheets. If recognized, $2.5 million of these unrecognized tax benefits would impact the Company’s effective tax rate. The Company recognizes estimated accrued interest related to unrecognized income tax benefits in the provision for (benefit from) income tax accounts. Penalties relating to income taxes, if incurred, would also be recognized as a component of the Company’s provision for (benefit from) income taxes. Over the next 12 months, the amount of the Company’s liability for unrecognized tax benefits is not expected to change by a material amount. As of March 31, 2020, the amount of cumulative accrued interest expense on unrecognized income tax benefits was approximately $0.2 million. The following table summarizes the Company’s deferred tax assets, net of deferred tax liabilities and valuation allowance (in thousands), as of: March 31, December 31, 2020 2019 Deferred tax assets, net of deferred tax liabilities $ 20,252 $ 21,513 Valuation allowance (2,137 ) (2,130 ) Deferred tax assets, net of deferred tax liabilities and valuation allowance $ 18,115 $ 19,383 The valuation allowances as of March 31, 2020 and December 31, 2019 primarily related to certain foreign tax credit carryforwards that, in the Company’s present estimation, more likely than not will not be realized. The Company has estimated its annual effective tax rate for the full fiscal year 2020 and applied that rate to its income before income taxes in determining its provision for income taxes for the three months ended March 31, 2020. The Company also records discrete items in each respective period as appropriate. The estimated effective tax rate is subject to fluctuation based on the level and mix of earnings and losses by tax jurisdiction, foreign tax rate differentials, and the relative impact of permanent book to tax differences (e.g., non-deductible expenses). Each quarter, a cumulative adjustment is recorded for any fluctuations in the estimated annual effective tax rate as compared to the prior quarter. As a result of these factors, and due to potential changes in the Company’s period-to-period results, fluctuations in the Company’s effective tax rate and respective tax provisions or benefits may occur. For the three months ended March 31, 2020, the Company recorded a provision for income taxes of $1.6 million that resulted in an effective tax rate of 70.4%, as compared to a benefit from income taxes of $0.5 million that resulted in an effective tax rate of 6.1% for the three months ended March 31, 2019. The change in the effective tax rate in 2020 is mainly due to certain discrete items and the change in the expected proportion of U.S. versus foreign income. In the United States, the Tax Act reduced the U.S. corporate tax rate from 35% to 21%, effective January 1, 2018. Additionally, the Tax Act requires certain Global Intangible Low Taxed Income (“GILTI”) earned by controlled foreign corporations (“CFCs”) to be included in the gross income of the CFCs’ U.S. shareholder. The Company has elected the “period cost method” and treats taxes due on future U.S. inclusions in taxable income related to GILTI as a current-period expense when incurred. The Tax Act allows a U.S. corporation a deduction equal to a certain percentage of its foreign-derived intangible income (“FDII”). The Company estimated the impact of the GILTI tax and FDII deduction in determining its 2020 annual effective tax rate that is reflected in its provision for income taxes for the three months ended March 31, 2020. The Tax Act also imposed a Transition Tax on previously untaxed accumulated and current earnings and profits of certain foreign subsidiaries of the Company. As a result of the Tax Act, the Company recorded a final tax expense of $37.2 million related to the Transition Tax, comprised of a provisional Transition Tax obligation of $40.3 million in 2017 and a subsequent $(3.1) million measurement-period adjustment in 2018. As of March 31, 2020, $28.9 million of the Transition Tax was unpaid, of which $28.0 million was recorded in “Other long-term liabilities” and $0.9 million was recorded in “Accounts payable, accrued expenses, and operating lease liabilities” in the Company’s Consolidated Balance Sheets. The Company has elected to pay the Transition Tax over an eight-year period beginning in 2018, as permitted under the Tax Act. The Company earns a significant amount of its revenues outside the United States and, as of December 31, 2019, the Company’s accumulated foreign earnings and profits were $431.2 million. As of March 31, 2020 and December 31, 2019, the amount of cash and cash equivalents and short-term investments held by the Company’s U.S. entities was $245.8 million and $289.4 million, respectively, and by the Company’s non-U.S. entities was $293.4 million and $276.2 million, respectively. As of March 31, 2020, the Company intends to indefinitely reinvest $231.2 million of its undistributed foreign earnings. In determining the Company’s provision for (benefit from) income taxes, net deferred tax assets, liabilities, and valuation allowances, management is required to make estimates and judgments related to projections of domestic and foreign profitability, the timing and extent of the utilization of NOL carryforwards, applicable tax rates, transfer pricing methods, and prudent and feasible tax planning strategies. As a multinational company, the Company is required to calculate and provide for estimated income tax liabilities for each of the tax jurisdictions in which it operates. This process involves estimating current tax obligations and exposures in each jurisdiction, as well as making judgments regarding the future recoverability of deferred tax assets. Changes in the estimated level of annual pre-tax income, changes in tax laws, particularly changes related to the utilization of NOLs in various jurisdictions, and changes resulting from tax audits can all affect the overall effective income tax rate, which, in turn, impacts the overall level of income tax expense or benefit and net income. In the United States, the Coronavirus Aid, Relief, and Economic Security Act was enacted on March 27, 2020 to provide broad-based economic relief to various sectors of the U.S. economy through a variety of means, including payroll and income tax deferrals and employee retention credits. The Company is currently in the process of evaluating the various COVID-19 pandemic relief packages available to the Company in countries where it operates and their potential impact to its Consolidated Financial Statements. Estimates and judgments related to the Company’s projections and assumptions are inherently uncertain. Therefore, actual results could differ materially from projections. Currently, the Company expects to use its deferred tax assets, subject to Internal Revenue Code limitations, within the carryforward periods. Valuation allowances have been established where the Company has concluded that it is more likely than not that such deferred tax assets are not realizable. If the Company is unable to sustain or increase profitability in future periods, it may be required to increase the valuation allowance against the deferred tax assets, which could result in a charge that would materially adversely affect net income in the period in which the charge is incurred.

Share-based Compensation

Share-based Compensation	3 Months Ended
	Mar. 31, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Share-based Compensation	(9) Share-based Compensation The Company’s 2013 Stock Incentive Plan (as amended, the “2013 Equity Plan”) authorizes the issuance of various types of share-based awards to the Company’s employees, officers, directors, and other eligible participants. As of March 31, 2020, a total of 2,300,000 shares of the Company’s class A common stock were authorized for issuance under the 2013 Equity Plan. As of March 31, 2020, there were 391,850 shares of class A common stock reserved and available for future issuance under the 2013 Equity Plan. Stock option awards As of March 31, 2020, there were options to purchase 1,600,533 shares of class A common stock outstanding under the 2013 Equity Plan. The following table summarizes the Company’s stock option activity (in thousands, except per share data and years) for the three months ended March 31, 2020: Stock Options Outstanding Weighted Average Aggregate Weighted Average Exercise Price Intrinsic Remaining Contractual Shares Per Share Value Term (Years) Balance as of January 1, 2020 1,634 $ 141.60 Granted 0 $ 0 Exercised (3 ) $ 130.85 $ 53 Forfeited/Expired (30 ) $ 152.22 Balance as of March 31, 2020 1,601 $ 141.41 Exercisable as of March 31, 2020 925 $ 137.95 $ 0 4.9 Expected to vest as of March 31, 2020 676 $ 146.13 $ 0 9.0 Total 1,601 $ 141.41 $ 0 6.7 Stock options outstanding as of March 31, 2020 are comprised of the following range of exercise prices per share (in thousands, except per share data and years): Stock Options Outstanding at March 31, 2020 Weighted Average Weighted Average Exercise Price Remaining Contractual Range of Exercise Prices per Share Shares Per Share Term (Years) $119.02 - $140.00 941 $ 125.65 5.6 $140.01 - $160.00 412 $ 152.21 9.6 $160.01 - $180.00 95 $ 169.07 5.0 $180.01 - $201.25 153 $ 192.11 6.3 Total 1,601 $ 141.41 6.7 An aggregate of 99,375 stock options with an aggregate fair value of $5.6 million vested during the three months ended March 31, 2020. No stock option awards were granted during the three months ended March 31, 2020. The weighted average grant date fair value of stock option awards using the Black-Scholes pricing model was $54.85 for each share subject to a stock option granted during the three months ended March 31, 2019, based on the following assumptions: Three months ended March 31, 2019 Expected term of options in years 6.3 Expected volatility 33.4 % Risk-free interest rate 2.5 % Expected dividend yield 0.0 % For the three months ended March 31, 2020 and 2019 , the Company recognized approximately $ 3.2 million and $ 3.0 million, respectively, in share-based compensation expense from stock options granted under the 2013 Equity Plan. As of March 31, 2020 , there was approximately $ 32.7 million of total unrecognized share-based compensation expense related to unvested stock options. The Company expects to recognize this remaining share-based compensation expense over a weighted average vesting period of approximately 3.0 years . Other stock-based awards During the three months ended March 31, 2020, the Company did not grant any “other stock-based awards” under the 2013 Equity Plan. For each of the three months ended March 31, 2020 and 2019, the Company did not recognize a material amount of share-based compensation expense from other stock-based awards. As of March 31, 2020, there was approximately $0.2 million of total unrecognized share-based compensation expense related to other stock-based awards. The Company expects to recognize this remaining share-based compensation expense over a weighted average vesting period of approximately 2.2 years, subject to additional fair value adjustments through the earlier of settlement or expiration.

Common Equity and Earnings per

Common Equity and Earnings per Share	3 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Common Equity and Earnings per Share	(10) Common Equity and Earnings per Share The Company has two classes of common stock: class A common stock and class B common stock. Holders of class A common stock generally have the same rights, including rights to dividends, as holders of class B common stock, except that holders of class A common stock have one vote per share while holders of class B common stock have 10 votes per share. Each share of class B common stock is convertible at any time, at the option of the holder, into one share of class A common stock. As such, basic and fully diluted earnings per share for class A common stock and for class B common stock are the same. The Company has never declared or paid any cash dividends on either class A or class B common stock. As of March 31, 2020 and December 31, 2019, there were no shares of preferred stock issued or outstanding. Potential shares of common stock are included in the diluted earnings per share calculation when dilutive. Potential shares of common stock, consisting of common stock issuable upon exercise of outstanding stock options, are calculated using the treasury stock method. For the three months ended March 31, 2020 and 2019, stock options issued under the 2013 Equity Plan to purchase a weighted average of approximately 1,073,000 and 1,471,000 shares of class A common stock, respectively, were excluded from the diluted earnings per share calculation because their impact would have been anti-dilutive.

Segment Information

Segment Information	3 Months Ended
	Mar. 31, 2020
Segment Reporting [Abstract]
Segment Information	(11) Segment Information The Company manages its business in one reportable operating segment. The Company’s one reportable operating segment is engaged in the design, development, marketing, and sales of its software platform through licensing arrangements and cloud subscriptions and related services. The following table presents total revenues, gross profit, and long-lived assets, excluding long-term deferred tax assets, (in thousands) according to geographic region: Geographic regions: Domestic EMEA Other Regions Consolidated Three months ended March 31, 2020 Total revenues $ 65,489 $ 35,473 $ 10,462 $ 111,424 Gross profit $ 51,442 $ 27,176 $ 8,261 $ 86,879 Three months ended March 31, 2019 Total revenues $ 64,881 $ 37,675 $ 12,810 $ 115,366 Gross profit $ 49,534 $ 29,528 $ 10,131 $ 89,193 As of March 31, 2020 Long-lived assets $ 115,221 $ 12,341 $ 10,508 $ 138,070 As of December 31, 2019 Long-lived assets $ 118,168 $ 13,636 $ 11,912 $ 143,716 The domestic region consists of the United States and Canada. The EMEA region includes operations in Europe, the Middle East, and Africa. The other regions include all other foreign countries, generally comprising Latin America and the Asia Pacific region. For the three months ended March 31, 2020 and 2019, no individual foreign country accounted for 10% or more of total consolidated revenues. For the three months ended March 31, 2020 and 2019, no individual customer accounted for 10% or more of total consolidated revenues. As of March 31, 2020 and December 31, 2019, no individual foreign country accounted for 10% or more of total consolidated assets.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Basis of Presentation	(a) Basis of Presentation The accompanying Consolidated Financial Statements of MicroStrategy Incorporated (“MicroStrategy” or the “Company”) are unaudited. In the opinion of management, all adjustments necessary for a fair statement of financial position and results of operations have been included. All such adjustments are of a normal recurring nature, unless otherwise disclosed. Interim results are not necessarily indicative of results for a full year. Certain amounts in the prior year’s Consolidated Statements of Cash Flows have been reclassified to conform to current year presentation. In particular, reductions in the carrying amount of right-of-use (“ROU”) assets have been reclassified from “Depreciation and amortization” to “Reduction in carrying amount of right-of-use assets” in operating activities. As discussed in Note 2, Recent Accounting Standards, to the Consolidated Financial Statements, the Company adopted Accounting Standards Update No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, The Consolidated Financial Statements and Notes to Consolidated Financial Statements are presented as required by the United States Securities and Exchange Commission (“SEC”) and do not contain certain information included in the Company’s annual financial statements and notes. These financial statements should be read in conjunction with the Company’s audited financial statements and the notes thereto filed with the SEC in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019. There have been no significant changes in the Company’s accounting policies since December 31, 2019, except as discussed below with respect to the Company’s adoption of ASU 2016-13. The accompanying Consolidated Financial Statements include the accounts of the Company and its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. The Company is not aware of any material subsequent event that would require recognition or disclosure.
Short-term Investments	(b) Short-term Investments The Company periodically invests a portion of its excess cash in short-term investment instruments. All highly liquid investments with stated maturity dates between three months and one year from the purchase date are classified as short-term investments. The Company determines the appropriate classification of its short-term investments at the time of purchase and reassesses the appropriateness of the classification at each reporting date. All of the Company’s short-term investments are in U.S. Treasury securities. All short-term investments have been classified as available-for-sale and are reported at fair value within “Short-term investments” on the accompanying Consolidated Balance Sheets. The fair value of the Company’s short-term investments is determined based on quoted market prices in active markets for identical securities (Level 1 inputs). Premiums and discounts related to the Company’s short-term investments are amortized over the life of the investment and recorded in earnings. Each reporting period, the Company determines the amount of unrealized holding gains and losses on each individual security by comparing the fair value to the amortized cost. Unrealized holding gains and unrealized holding losses that are not a result of a credit loss are reported in other comprehensive income (loss) until realized. Beginning January 1, 2020, unrealized holding losses that are a result of a credit loss are recorded in earnings, with the establishment of an allowance for credit losses.
Credit Losses on Accounts Receivable	(c) Credit Losses on Accounts Receivable The Company maintains an allowance for credit losses on its accounts receivable balances, which represents its best estimate of current expected credit losses over the contractual life of the accounts receivable. Beginning January 1, 2020, when evaluating the adequacy of its allowance for credit losses each reporting period, the Company analyzes accounts receivable balances with similar risk characteristics on a collective basis, considering factors such as the aging of receivable balances, payment terms, geographic location, historical loss experience, current information, and future expectations. Each reporting period, the Company reassesses whether any accounts receivable no longer share similar risk characteristics and should instead be evaluated as part of another pool or on an individual basis. Changes to the allowance for credit losses are adjusted through credit loss expense, which is presented within “General and administrative” operating expenses in the Consolidated Statements of Operations.
Income Taxes	The Company recognizes estimated accrued interest related to unrecognized income tax benefits in the provision for (benefit from) income tax accounts.Additionally, the Tax Act requires certain Global Intangible Low Taxed Income (“GILTI”) earned by controlled foreign corporations (“CFCs”) to be included in the gross income of the CFCs’ U.S. shareholder. The Company has elected the “period cost method” and treats taxes due on future U.S. inclusions in taxable income related to GILTI as a current-period expense when incurred. The Tax Act allows a U.S. corporation a deduction equal to a certain percentage of its foreign-derived intangible income (“FDII”).In determining the Company’s provision for (benefit from) income taxes, net deferred tax assets, liabilities, and valuation allowances, management is required to make estimates and judgments related to projections of domestic and foreign profitability, the timing and extent of the utilization of NOL carryforwards, applicable tax rates, transfer pricing methods, and prudent and feasible tax planning strategies. As a multinational company, the Company is required to calculate and provide for estimated income tax liabilities for each of the tax jurisdictions in which it operates. This process involves estimating current tax obligations and exposures in each jurisdiction, as well as making judgments regarding the future recoverability of deferred tax assets. Changes in the estimated level of annual pre-tax income, changes in tax laws, particularly changes related to the utilization of NOLs in various jurisdictions, and changes resulting from tax audits can all affect the overall effective income tax rate, which, in turn, impacts the overall level of income tax expense or benefit and net income. Estimates and judgments related to the Company’s projections and assumptions are inherently uncertain. Therefore, actual results could differ materially from projections. Currently, the Company expects to use its deferred tax assets, subject to Internal Revenue Code limitations, within the carryforward periods. Valuation allowances have been established where the Company has concluded that it is more likely than not that such deferred tax assets are not realizable. If the Company is unable to sustain or increase profitability in future periods, it may be required to increase the valuation allowance against the deferred tax assets, which could result in a charge that would materially adversely affect net income in the period in which the charge is incurred.
Basic and Diluted Earnings per Share	Potential shares of common stock are included in the diluted earnings per share calculation when dilutive. Potential shares of common stock, consisting of common stock issuable upon exercise of outstanding stock options, are calculated using the treasury stock method.

Contract Balances (Tables)

Contract Balances (Tables)	3 Months Ended
	Mar. 31, 2020
Contract With Customer Asset And Liability [Abstract]
Schedule of Accounts Receivable	Accounts receivable (in thousands) consisted of the following, as of: March 31, December 31, 2020 2019 Billed and billable $ 126,971 $ 165,153 Less: allowance for credit losses (2,036 ) (1,637 ) Accounts receivable, net $ 124,935 $ 163,516
Deferred Revenue and Advance Payments	Deferred revenue and advance payments (in thousands) from customers consisted of the following, as of: March 31, December 31, 2020 2019 Current: Deferred product licenses revenue $ 131 $ 481 Deferred subscription services revenue 16,567 16,561 Deferred product support revenue 161,135 161,670 Deferred other services revenue 7,058 8,395 Total current deferred revenue and advance payments $ 184,891 $ 187,107 Non-current: Deferred product licenses revenue $ 262 $ 293 Deferred subscription services revenue 84 97 Deferred product support revenue 2,789 3,417 Deferred other services revenue 525 537 Total non-current deferred revenue and advance payments $ 3,660 $ 4,344

Income Taxes (Tables)

Income Taxes (Tables)	3 Months Ended
	Mar. 31, 2020
Income Tax Disclosure [Abstract]
Company's Deferred Tax Assets, Net of Deferred Tax Liabilities and Valuation Allowance	The following table summarizes the Company’s deferred tax assets, net of deferred tax liabilities and valuation allowance (in thousands), as of: March 31, December 31, 2020 2019 Deferred tax assets, net of deferred tax liabilities $ 20,252 $ 21,513 Valuation allowance (2,137 ) (2,130 ) Deferred tax assets, net of deferred tax liabilities and valuation allowance $ 18,115 $ 19,383

Share-based Compensation (Table

Share-based Compensation (Tables)	3 Months Ended
	Mar. 31, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Summary of Stock Option Activity	The following table summarizes the Company’s stock option activity (in thousands, except per share data and years) for the three months ended March 31, 2020: Stock Options Outstanding Weighted Average Aggregate Weighted Average Exercise Price Intrinsic Remaining Contractual Shares Per Share Value Term (Years) Balance as of January 1, 2020 1,634 $ 141.60 Granted 0 $ 0 Exercised (3 ) $ 130.85 $ 53 Forfeited/Expired (30 ) $ 152.22 Balance as of March 31, 2020 1,601 $ 141.41 Exercisable as of March 31, 2020 925 $ 137.95 $ 0 4.9 Expected to vest as of March 31, 2020 676 $ 146.13 $ 0 9.0 Total 1,601 $ 141.41 $ 0 6.7
Schedule of Range of Exercise Prices per Share	Stock options outstanding as of March 31, 2020 are comprised of the following range of exercise prices per share (in thousands, except per share data and years): Stock Options Outstanding at March 31, 2020 Weighted Average Weighted Average Exercise Price Remaining Contractual Range of Exercise Prices per Share Shares Per Share Term (Years) $119.02 - $140.00 941 $ 125.65 5.6 $140.01 - $160.00 412 $ 152.21 9.6 $160.01 - $180.00 95 $ 169.07 5.0 $180.01 - $201.25 153 $ 192.11 6.3 Total 1,601 $ 141.41 6.7
Assumptions Used in Black-Scholes Pricing Model	The weighted average grant date fair value of stock option awards using the Black-Scholes pricing model was $54.85 for each share subject to a stock option granted during the three months ended March 31, 2019, based on the following assumptions: Three months ended March 31, 2019 Expected term of options in years 6.3 Expected volatility 33.4 % Risk-free interest rate 2.5 % Expected dividend yield 0.0 %

Segment Information (Tables)

Segment Information (Tables)	3 Months Ended
	Mar. 31, 2020
Segment Reporting [Abstract]
Revenues and Long-Lived Assets, by Geographic Region	The following table presents total revenues, gross profit, and long-lived assets, excluding long-term deferred tax assets, (in thousands) according to geographic region: Geographic regions: Domestic EMEA Other Regions Consolidated Three months ended March 31, 2020 Total revenues $ 65,489 $ 35,473 $ 10,462 $ 111,424 Gross profit $ 51,442 $ 27,176 $ 8,261 $ 86,879 Three months ended March 31, 2019 Total revenues $ 64,881 $ 37,675 $ 12,810 $ 115,366 Gross profit $ 49,534 $ 29,528 $ 10,131 $ 89,193 As of March 31, 2020 Long-lived assets $ 115,221 $ 12,341 $ 10,508 $ 138,070 As of December 31, 2019 Long-lived assets $ 118,168 $ 13,636 $ 11,912 $ 143,716

Recent Accounting Standards - A

Recent Accounting Standards - Additional Information (Detail) - USD ($)	Mar. 31, 2020	Jan. 01, 2020
Minimum | US Treasury Securities
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Available-for-sale securities maturity range	3 months
Maximum | US Treasury Securities
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Available-for-sale securities maturity range	1 year
ASU 2016-13
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Cumulative-effect adjustment to retained earnings		$ 0

Short-term Investments - Additi

Short-term Investments - Additional Information (Detail) - US Treasury Securities - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Summary Of Investment Holdings [Line Items]
Available-for-sale securities, amortized cost	$ 109,200	$ 108,800
Available-for-sale securities, fair value	109,900	108,900
Available-for-sale securities, unrealized loss position	$ 0	$ 0

Schedule of Accounts Receivable

Schedule of Accounts Receivable (Detail) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Receivables [Abstract]
Billed and billable	$ 126,971	$ 165,153
Less: allowance for credit losses	(2,036)	(1,637)
Accounts receivable, net	$ 124,935	$ 163,516

Contract Balances - Additional

Contract Balances - Additional Information (Detail) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Contract With Customer Asset And Liability [Line Items]
Revenue, Remaining performance obligation	$ 188,600,000
Prepaid Expenses and Other Current Assets
Contract With Customer Asset And Liability [Line Items]
Assets impairment charges	0		$ 0
Contract assets	1,100,000		$ 1,200,000
Current Deferred Revenue and Advanced Payments
Contract With Customer Asset And Liability [Line Items]
Revenue recognized from beginning deferred revenue	$ 69,200,000	$ 67,000,000

Deferred Revenue and Advance Pa

Deferred Revenue and Advance Payments (Detail) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Deferred Revenue Disclosure [Abstract]
Deferred product licenses revenue, Current	$ 131	$ 481
Deferred subscription services revenue, Current	16,567	16,561
Deferred product support revenue, Current	161,135	161,670
Deferred other services revenue, Current	7,058	8,395
Total current deferred revenue and advance payments	184,891	187,107
Deferred product licenses revenue, Non-current	262	293
Deferred subscription services revenue, Non-current	84	97
Deferred product support revenue, Non-current	2,789	3,417
Deferred other services revenue, Non-current	525	537
Total non-current deferred revenue and advance payments	$ 3,660	$ 4,344

Contract Balances - Additiona_2

Contract Balances - Additional Information (Detail1) $ in Millions	Mar. 31, 2020USD ($)
Contract With Customer Asset And Liability [Line Items]
Revenue, Remaining performance obligation	$ 188.6
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2020-04-01
Contract With Customer Asset And Liability [Line Items]
Revenue, Remaining performance obligations, Expected timing of satisfaction, Period	12 months
Revenue, Remaining performance obligation	$ 184.9
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2021-04-01
Contract With Customer Asset And Liability [Line Items]
Revenue, Remaining performance obligations, Expected timing of satisfaction, Period
Revenue, Remaining performance obligation	$ 3.7

Leases - Additional Information

Leases - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Operating Leased Assets [Line Items]
Operating lease, right of use asset	$ 82,690		$ 85,538
Right of use asset obtained in exchange for operating lease liability	0	$ 1,000
UNITED STATES
Operating Leased Assets [Line Items]
Operating lease, right of use asset	69,900		71,000
Operating lease, liability	96,100		97,500
UNITED STATES | Northern Virginia Office Space
Operating Leased Assets [Line Items]
Operating lease, right of use asset	66,000		66,900
Operating lease, liability	92,100		93,300
Non-US
Operating Leased Assets [Line Items]
Operating lease, right of use asset	12,800		14,500
Operating lease, liability	$ 13,700		$ 15,500

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) - Feb. 06, 2020 R$ in Millions, $ in Millions	USD ($)	BRL (R$)
Commitments And Contingencies Disclosure [Abstract]
Maximum amount frozen in Brazilian subsidiary bank accounts	$ 2.3	R$ 10.0

Treasury Stock - Additional Inf

Treasury Stock - Additional Information (Detail) - USD ($)	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019
Equity, Class of Treasury Stock [Line Items]
Treasury stock, shares repurchased value	$ 50,747,000	$ 24,475,000	$ 48,244,000
Treasury stock, shares	8,162,000	7,807,000
Treasury stock, cost	$ 709,627,000	$ 658,880,000
Class A
Equity, Class of Treasury Stock [Line Items]
Treasury stock, shares repurchased	0	0	0
Treasury stock, shares repurchased value	$ 0	$ 0	$ 0
Class A | Share Repurchase Program
Equity, Class of Treasury Stock [Line Items]
Shares repurchased program expiration date	Apr. 29, 2023
Stock authorized to repurchase by board of directors	$ 800,000,000
Treasury stock, shares repurchased	354,633		362,148
Shares repurchased, average price per share	$ 143.10		$ 133.21
Treasury stock, shares repurchased value	$ 50,700,000		$ 48,200,000
Treasury stock, shares	5,584,090
Shares repurchased, average price per share	$ 103.82
Treasury stock, cost	$ 579,700,000
Stock remaining available for repurchase	$ 220,300,000

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2019
Income Taxes
Unrecognized tax benefits	$ 2,600
Unrecognized tax benefits would impact the effective tax rate	2,500
Interest accrued	$ 200
Effective tax rate from operations	70.40%	6.10%
Provision for (benefit from) income taxes	$ 1,560	$ (510)
Effective U.S corporate tax rate	21.00%			35.00%
Provision for transition tax			$ 37,200	$ 40,300
Measurement period adjustment to reduce transition tax			$ (3,100)
Transition tax, unpaid	$ 28,900
Transition Tax over an eight-year period beginning	2018
Retained earnings	$ 584,146				$ 583,489
Undistributed foreign earnings	231,200
Other Long-term Liabilities
Income Taxes
Transition tax, unpaid	28,000
Accounts Payable, Accrued Expenses and Operating Lease Liabilities
Income Taxes
Transition tax, unpaid	900
U.S
Income Taxes
Cash and cash equivalents and short-term investments	$ 245,800				289,400
U.S | Earliest Tax Year
Income Taxes
Tax years subject to examination	2016
Italy | Earliest Tax Year
Income Taxes
Tax years subject to examination	2016
Poland | Earliest Tax Year
Income Taxes
Tax years subject to examination	2015
Spain | Earliest Tax Year
Income Taxes
Tax years subject to examination	2016
United Kingdom | Earliest Tax Year
Income Taxes
Tax years subject to examination	2018
Germany | Earliest Tax Year
Income Taxes
Tax years subject to examination	2016
Foreign
Income Taxes
Cash and cash equivalents and short-term investments	$ 293,400				276,200
Retained earnings					$ 431,200

Company's Deferred Tax Assets,

Company's Deferred Tax Assets, Net of Deferred Tax Liabilities and Valuation Allowance (Detail) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Deferred tax assets, net of deferred tax liabilities	$ 20,252	$ 21,513
Valuation allowance	(2,137)	(2,130)
Deferred tax assets, net of deferred tax liabilities and valuation allowance	$ 18,115	$ 19,383

Share-based Compensation - Addi

Share-based Compensation - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Stock Option Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options outstanding, shares	1,601,000		1,634,000
Stock option awards granted	0
2013 Equity Plan | Stock Option Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options vested	99,375
Aggregate fair value of stock option vested	$ 5.6
Weighted average grant date fair value of stock option awards		$ 54.85
Stock option awards granted	0
Share-based compensation expense recognized	$ 3.2	$ 3
Unrecognized share-based compensation expense	$ 32.7
Unrecognized compensation expense expected to be recognized	3 years
2013 Equity Plan | Other Stock-based Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation expense expected to be recognized	2 years 2 months 12 days
Other stock-based awards granted	0
Unrecognized share-based compensation expense	$ 0.2
2013 Equity Plan | Class A | Stock Option Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options outstanding, shares	1,600,533
2013 Equity Plan | Class A | Employees, Officers, and Directors
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation, stock authorized	2,300,000
Shares of class A common stock reserved and available for future issuance	391,850

Summary of Stock Option Activit

Summary of Stock Option Activity (Detail) - Stock Option Awards $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2020USD ($)$ / sharesshares
Options outstanding, shares
Beginning Balance | shares	1,634
Granted | shares	0
Exercised | shares	(3)
Forfeited/Expired | shares	(30)
Ending Balance | shares	1,601
Exercisable as of March 31, 2020 | shares	925
Expected to vest as of March 31, 2020 | shares	676
Total | shares	1,601
Weighted Average Exercise Price Per Share
Beginning Balance | $ / shares	$ 141.60
Granted | $ / shares	0
Exercised | $ / shares	130.85
Forfeited/Expired | $ / shares	152.22
Ending Balance | $ / shares	141.41
Exercisable as of March 31, 2020 | $ / shares	137.95
Expected to vest as of March 31, 2020 | $ / shares	146.13
Total | $ / shares	$ 141.41
Aggregate Intrinsic Value
Exercised | $	$ 53
Exercisable as of March 31, 2020 | $	0
Expected to vest as of March 31, 2020 | $	0
Total | $	$ 0
Weighted Average Remaining Contractual Term (Years)
Exercisable as of March 31, 2020	4 years 10 months 24 days
Expected to vest as of March 31, 2020	9 years
Total	6 years 8 months 12 days

Schedule of Range of Exercise P

Schedule of Range of Exercise Prices per Share (Detail) - Stock Option Awards shares in Thousands	3 Months Ended
	Mar. 31, 2020$ / sharesshares
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Shares, Stock Options Outstanding | shares	1,601
Weighted Average Exercise Price Per Share, Stock Options Outstanding	$ 141.41
Weighted Average Remaining Contractual Term (Years), Stock Options Outstanding	6 years 8 months 12 days
119.02 - 140.00
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices per Share, minimum	$ 119.02
Range of Exercise Prices per Share, maximum	$ 140
Shares, Stock Options Outstanding | shares	941
Weighted Average Exercise Price Per Share, Stock Options Outstanding	$ 125.65
Weighted Average Remaining Contractual Term (Years), Stock Options Outstanding	5 years 7 months 6 days
140.01 - 160.00
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices per Share, minimum	$ 140.01
Range of Exercise Prices per Share, maximum	$ 160
Shares, Stock Options Outstanding | shares	412
Weighted Average Exercise Price Per Share, Stock Options Outstanding	$ 152.21
Weighted Average Remaining Contractual Term (Years), Stock Options Outstanding	9 years 7 months 6 days
160.01 - 180.00
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices per Share, minimum	$ 160.01
Range of Exercise Prices per Share, maximum	$ 180
Shares, Stock Options Outstanding | shares	95
Weighted Average Exercise Price Per Share, Stock Options Outstanding	$ 169.07
Weighted Average Remaining Contractual Term (Years), Stock Options Outstanding	5 years
180.01 - 201.25
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices per Share, minimum	$ 180.01
Range of Exercise Prices per Share, maximum	$ 201.25
Shares, Stock Options Outstanding | shares	153
Weighted Average Exercise Price Per Share, Stock Options Outstanding	$ 192.11
Weighted Average Remaining Contractual Term (Years), Stock Options Outstanding	6 years 3 months 18 days

Assumptions Used in Black-Schol

Assumptions Used in Black-Scholes Pricing Model (Detail) - Stock Option Awards	3 Months Ended
	Mar. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term of options in years	6 years 3 months 18 days
Expected volatility	33.40%
Risk-free interest rate	2.50%
Expected dividend yield	0.00%

Common Equity and Earnings pe_2

Common Equity and Earnings per Share - Additional Information (Detail) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Class of Stock
Payments of dividends, common stock	$ 0		$ 0
Preferred stock, shares issued	0		0
Preferred stock, shares outstanding	0		0
Class A
Class of Stock
Common stock, votes per share	one
Class A | 2013 Plan
Class of Stock
Shares issuable under stock options excluded from calculation of diluted earnings per share	1,073,000	1,471,000
Class B Convertible
Class of Stock
Common stock, votes per share	10

Segment Information - Additiona

Segment Information - Additional Information (Detail)	3 Months Ended
	Mar. 31, 2020SegmentCountryCustomer	Mar. 31, 2019CountryCustomer	Dec. 31, 2019Country
Segment Reporting Information
Number of operating segments | Segment	1
Geographic Concentration Risk
Segment Reporting Information
Number Of Individual Country accounted for 10% or more of total revenues	0	0
Number Of Individual country accounted for 10% or more of total consolidated assets	0		0
Customer Concentration Risk | Sales Revenue, Goods, Net
Segment Reporting Information
Number Of Individual Customer accounted for 10% or more of total consolidated revenues | Customer	0	0

Total Revenues Gross Profit and

Total Revenues Gross Profit and Long Lived Assets Excluding Long Term Deferred Tax Assets (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Revenues from External Customers and Long-Lived Assets
Total revenues	$ 111,424	$ 115,366
Gross profit	86,879	89,193
Long-lived assets	138,070		$ 143,716
Domestic
Revenues from External Customers and Long-Lived Assets
Total revenues	65,489	64,881
Gross profit	51,442	49,534
Long-lived assets	115,221		118,168
EMEA
Revenues from External Customers and Long-Lived Assets
Total revenues	35,473	37,675
Gross profit	27,176	29,528
Long-lived assets	12,341		13,636
Other Regions
Revenues from External Customers and Long-Lived Assets
Total revenues	10,462	12,810
Gross profit	8,261	$ 10,131
Long-lived assets	$ 10,508		$ 11,912